CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma
Open Access
- 19 January 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (1), e0245524
- https://doi.org/10.1371/journal.pone.0245524
Abstract
Lower-grade glioma (LGG) is the most common histology identified in glioma. CKMT1B has not been investigated in glioma. The purpose of this research was to investigate the prognostic value of CKMT1B and its correlation with immune infiltration in LGG. We used Gene Expression Profiling Interactive Analysis (GEPIA) to analyze the expression of CKMT1B in LGG. Univariate and multivariate Cox regression analyses were used to assess the effect of CKMT1B expression and screened variables on survival. The correlation between CKMT1B and immune infiltration was evaluated by TIMER and CIBERSORT. Moreover, the possible biological functions of CKMT1B were studied by GSEA. The statistical analysis was conducted by R software. The expression of CKMT1B was significantly lower than the normal samples in LGG. Low expression of CKMT1B predicts a worse prognosis. Multivariate Cox analyses revealed that CKMT1B might be an independent favorable prognostic indicator. TIMER analysis revealed that CKMT1B expression level was related to immune infiltration. CIBERSORT analysis showed that CKMT1B expression was positively related to the infiltration level of activated mast cells and negatively related to macrophage M2 in LGG. Moreover, GESA showed that multiple cancer-related and immune-related gene sets were enriched in the low-CKMT1B group in the top 5 of the most significant differences. CKMT1B is a prognostic biomarker with potential applications and associated with immune infiltration in Lower-grade glioma.Keywords
Funding Information
- Jiangsu Agricultural Science and Technology Independent Innovation Fund (190712174542055)
This publication has 37 references indexed in Scilit:
- SnapShot: TCGA-Analyzed TumorsCell, 2018
- The Expression of Ubiquitous Mitochondrial Creatine Kinase Is Downregulated as Prostate Cancer ProgressionJournal of Cancer, 2016
- High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potentialInternational Journal of Cancer, 2013
- Chemotherapy in low-grade gliomasCurrent Opinion in Oncology, 2012
- Overexpression of ubiquitous mitochondrial creatine kinase (uMtCK) accelerates tumor growth by inhibiting apoptosis of breast cancer cells and is associated with a poor prognosis in breast cancer patientsBiochemical and Biophysical Research Communications, 2012
- Management of Low-Grade GliomaCurrent Neurology and Neuroscience Reports, 2010
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Mitochondrial creatine kinase in human health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinomaBritish Journal of Cancer, 2006
- Altered brain phosphocreatine and ATP regulation when mitochondrial creatine kinase is absentJournal of Neuroscience Research, 2001